Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: Questions, answers and demands for a common language
β Scribed by Pietro Majno; Vincenzo Mazzaferro
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 123 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20808
No coin nor oath required. For personal study only.
β¦ Synopsis
In this issue of Liver Transplantation two studies bring new data to the topic of living-donor transplantation (LDLT) for hepatocellular carcinoma (HCC), offering the opportunity for some comments. 1,2 Since LDLT became available, two concerns have puzzled hepatologists and surgeons involved with HCC.
π SIMILAR VOLUMES
In the present study, the results of living donor liver transplantation (LDLT) for 125 hepatocellular carcinoma (HCC) patients were analyzed to determine optimal criteria exceeding the Milan criteria (MC) but still with predictably good outcomes. On the basis of pretransplant imaging studies, 70 pat
Liver transplantation (LT) is the treatment of choice for early hepatocellular carcinoma (HCC) in patients with end-stage liver disease but is limited by the availability of donor organs. Living donor liver transplantation (LDLT) represents an alternative therapeutic option for patients with disease
In regions with a limited deceased donor pool, living donor adult liver transplantation (LDALT) has become an important treatment modality for patients with hepatocellular carcinoma (HCC) and cirrhosis. Studies have shown higher recurrence rates of HCC after LDALT in comparison with deceased donor l
The currently available indication criteria of living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC) have high prognostic power but insufficient discriminatory power. On the basis of single-center results from 221 HCC patients undergoing LDLT, we modified the ind